Discontinuation of Medical Cannabis Common in Musculoskeletal Pain
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 26, 2025 -- A number of patients with musculoskeletal pain discontinue medical cannabis (MC) within one year, with many discontinuing within the first three months, according to a study published online Aug. 7 in PLOS ONE.
Mohammad Khak, M.D., M.P.H., from the Rothman Institute Foundation for Opioid Research & Education in Philadelphia, and colleagues examined the rates of MC discontinuation and explored factors influencing discontinuation in patients with chronic musculoskeletal pain in a retrospective analysis. The study included 78 patients certified for MC during a two-year period. Patient demographics, pain origin, and Global Physical Health (GPH) and Global Mental Health (GMH) scores were obtained before the intervention, and discontinuation rates were measured at follow-up of three months and one year.
The researchers found that the overall discontinuation rate of MC use was 57.9 percent at one year; within the first three months, 44.7 percent of patients discontinued. There was a significant association for older age with higher discontinuation rates. There was no significant difference in pain origin categories for those who discontinued and continued MC use. Low back pain was reported by a higher proportion of patients in the discontinued group. Baseline GPH and GMH scores did not differ significantly between the groups.
"These findings suggest that while MC may offer benefits for some patients, further research is needed to better understand the long-term effects of MC on pain management and patient satisfaction, as well as the factors influencing treatment adherence," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
AAP Offers Guidance for Tapering of Opioids to Prevent Withdrawal in Children
TUESDAY, Aug. 19, 2025 -- A plan for tapering opioids should be developed to minimize withdrawal symptoms in children receiving opioids for five or more days, according to a...
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
WEDNESDAY, Aug. 6, 2025 -- Cognitive functional therapy (CFT), with or without biofeedback, is more effective than usual care for treating patients with chronic disabling low back...
Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery
TUESDAY, July 29, 2025 -- Opioid-limiting pain management education and counseling reduce opioid consumption with no increase in postoperative pain among patients undergoing...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.